Peptonic Medical
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här The District Court rejects the claim for a corporate fine and acquits all in insider case
The judgment relates to the investigation of serious insider crime that Peptonic previously informed about and which are related to measures taken by the company within the framework of a financing arrangement between the company and a financial actor in the spring of 2019. At the beginning of 2022, Peptonic was informed that EBM intended to claim a corporate fine for Peptonic of SEK 500,000 due to the investigation. EBM reiterated its claim in September 2022 in connection with the former chairman, CEO and CFO of the company being charged with serious insider crime. According to the judgment from the District Court, the accused persons and the company are now acquitted on all counts.
Peptonic reserved an amount corresponding to the corporate fine in its third quarter 2022 results. Peptonic intends to decide to dissolve the reserve in connection with results for the second quarter of 2023.
This disclosure contains information that PEPTONIC Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 28-06-2023 16:11 CET.